BACKGROUND: Raising the cholesterol of high-density lipoprotein (HDL) particles is targeted as a cardiovascular disease prevention strategy. However, HDL particles are heterogeneous in composition and structure, which may relate to differences in antiatherogenic potential. We prospectively evaluated the association of HDL subclasses, defined by a recently proposed nomenclature, with incident coronary heart disease (CHD). METHODS AND RESULTS: Baseline HDL particle concentrations were measured by nuclear magnetic resonance spectroscopy and categorized into 5 subclasses (very large, large, medium, small, and very small) among 26 332 initially healthy women. During a median follow-up of 17 years, 969 cases of incident CHD (myocardial infarction, revascularization, and CHD death) were ascertained. In Cox models that adjusted for age, race/ethnicity, blood pressure, smoking, postmenopausal status, and hormone therapy, associations with incident CHD were inverse (P trend<0.0001) for concentrations of very large (hazard ratio for top versus bottom quartile, 0.49; 95% confidence interval, 0.41-0.60), large (0.54; 0.45-0.64), and medium (0.69; 0.58-0.83) HDL subclasses. Conversely, hazard ratios (95% confidence intervals) for small and very small HDL were 1.22 (1.01-1.46; P trend=0.08) and 1.67 (1.39-2.02; P trend<0.0001), respectively. However, after additionally adjusting for metabolic and lipoprotein variables, associations for the spectrum of large, medium, and small HDL subclasses were inverse (P trend<0.05 for large and small and 0.07 for medium), whereas subclasses at either end of the spectrum were not associated with CHD (P trend=0.97 for very large and 0.21 for very small HDL). CONCLUSIONS: In this prospective study, associations with incident CHD differed by HDL particle subclass, which may be relevant for developing HDL-modulating therapies. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00000479.
BACKGROUND: Raising the cholesterol of high-density lipoprotein (HDL) particles is targeted as a cardiovascular disease prevention strategy. However, HDL particles are heterogeneous in composition and structure, which may relate to differences in antiatherogenic potential. We prospectively evaluated the association of HDL subclasses, defined by a recently proposed nomenclature, with incident coronary heart disease (CHD). METHODS AND RESULTS: Baseline HDL particle concentrations were measured by nuclear magnetic resonance spectroscopy and categorized into 5 subclasses (very large, large, medium, small, and very small) among 26 332 initially healthy women. During a median follow-up of 17 years, 969 cases of incident CHD (myocardial infarction, revascularization, and CHD death) were ascertained. In Cox models that adjusted for age, race/ethnicity, blood pressure, smoking, postmenopausal status, and hormone therapy, associations with incident CHD were inverse (P trend<0.0001) for concentrations of very large (hazard ratio for top versus bottom quartile, 0.49; 95% confidence interval, 0.41-0.60), large (0.54; 0.45-0.64), and medium (0.69; 0.58-0.83) HDL subclasses. Conversely, hazard ratios (95% confidence intervals) for small and very small HDL were 1.22 (1.01-1.46; P trend=0.08) and 1.67 (1.39-2.02; P trend<0.0001), respectively. However, after additionally adjusting for metabolic and lipoprotein variables, associations for the spectrum of large, medium, and small HDL subclasses were inverse (P trend<0.05 for large and small and 0.07 for medium), whereas subclasses at either end of the spectrum were not associated with CHD (P trend=0.97 for very large and 0.21 for very small HDL). CONCLUSIONS: In this prospective study, associations with incident CHD differed by HDL particle subclass, which may be relevant for developing HDL-modulating therapies. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00000479.
Authors: Bela F Asztalos; L Adrienne Cupples; Serkalem Demissie; Katalin V Horvath; Caitlin E Cox; Marcelo C Batista; Ernst J Schaefer Journal: Arterioscler Thromb Vasc Biol Date: 2004-09-23 Impact factor: 8.311
Authors: Sarah Parish; Alison Offer; Robert Clarke; Jemma C Hopewell; Michael R Hill; James D Otvos; Jane Armitage; Rory Collins Journal: Circulation Date: 2012-04-26 Impact factor: 29.690
Authors: Rachel H Mackey; Philip Greenland; David C Goff; Donald Lloyd-Jones; Christopher T Sibley; Samia Mora Journal: J Am Coll Cardiol Date: 2012-07-11 Impact factor: 24.094
Authors: B Lamarche; S Moorjani; B Cantin; G R Dagenais; P J Lupien; J P Després Journal: Arterioscler Thromb Vasc Biol Date: 1997-06 Impact factor: 8.311
Authors: A R Sharrett; C M Ballantyne; S A Coady; G Heiss; P D Sorlie; D Catellier; W Patsch Journal: Circulation Date: 2001-09-04 Impact factor: 29.690
Authors: Griffith Bell; Samia Mora; Philip Greenland; Michael Tsai; Ed Gill; Joel D Kaufman Journal: Arterioscler Thromb Vasc Biol Date: 2017-04-13 Impact factor: 8.311
Authors: Orlando M Gutiérrez; Suzanne E Judd; Marguerite R Irvin; Degui Zhi; Nita Limdi; Nicholette D Palmer; Stephen S Rich; Michèle M Sale; Barry I Freedman Journal: Nephrol Dial Transplant Date: 2015-07-06 Impact factor: 5.992
Authors: Parag H Joshi; Peter P Toth; Seth T Lirette; Michael E Griswold; Joseph M Massaro; Seth S Martin; Michael J Blaha; Krishnaji R Kulkarni; Arif A Khokhar; Adolfo Correa; Ralph B D'Agustino; Steven R Jones Journal: Eur J Prev Cardiol Date: 2014-07-25 Impact factor: 7.804
Authors: Maria M Llabre; William Arguelles; Neil Schneiderman; Linda C Gallo; Martha L Daviglus; Earle C Chambers; Daniela Sotres-Alvarez; Diana A Chirinos; Gregory A Talavera; Sheila F Castaneda; Scott C Roesch; Gerardo Heiss Journal: Ann Epidemiol Date: 2015-02-19 Impact factor: 3.797
Authors: Brian T Steffen; Suzette J Bielinski; Paul A Decker; Cecilia Berardi; Nicholas B Larson; James S Pankow; Erin D Michos; Naomi Q Hanson; David M Herrington; Michael Y Tsai Journal: J Clin Lipidol Date: 2017-06-13 Impact factor: 4.766
Authors: Samantha A Reina; Maria M Llabre; Matthew A Allison; John T Wilkins; Armando J Mendez; Martinson K Arnan; Neil Schneiderman; Ralph L Sacco; Mercedes Carnethon; J A Chris Delaney Journal: Atherosclerosis Date: 2015-09-28 Impact factor: 5.162
Authors: Sara Fernández-Castillejo; Rosa-Maria Valls; Olga Castañer; Laura Rubió; Úrsula Catalán; Anna Pedret; Alba Macià; Maureen L Sampson; María-Isabel Covas; Montserrat Fitó; Maria-José Motilva; Alan T Remaley; Rosa Solà Journal: Mol Nutr Food Res Date: 2016-05-06 Impact factor: 5.914